It does not replace a hormone optimization program, a longevity peptide cycle, or a metabolic peptide for weight loss
Obesity is a chronic disease, and people living with obesity deserve treatment options that match the complex biology of their neurometabolic disease, said Ania Jastreboff, MD, PhD, Lead Investigator and Director of the Yale Obesity Research Center
doi: 10.4314/ahs.v19i3.49
This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License ( which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
GHK-Cu remains an interesting molecule with a plausible mechanism and a generally favorable topical tolerability profile
While theres no evidence of any GLP-1 medications interacting with alcohol, many people reported that they had a decreased desire to consume alcoholic beverages while taking a GLP-1 medication, so this may be an easier adjustment than youd expect